Skip to content

Comparison of the postoperative analgesic effects of ultrasound-guided erector spinae plane block and thoracoscopic intercostal nerve block following video-assisted thoracoscopic lung surgery: a prospective randomized controlled trial

Comparison of the postoperative analgesic effects of ultrasound-guided erector spinae plane block and thoracoscopic intercostal nerve block following video-assisted thoracoscopic lung surgery: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092927
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-11-30
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoscopic lung surgery

Interventions

intercostal nerve block group (INCB group):Performing intercostal nerve block with liposomal bupivacaine under direct thoracoscopy at the end of the operation
erector spinae plane block group (ESPB group):Performing erector spinae plane nerve block with liposomal bupivacaine under ultrasound guidance at the end of the procedure

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.ASA class I-III; 2.Aged 18-75 years; 3.Subjects scheduled for elective video-assisted thoracoscopic lung surgery under general anesthesia with bronchial intubation.

Exclusion criteria

Exclusion criteria: 1.Subjects with sinus bradycardia (HR < 50 bpm) or heart conduction block (sinus block or atrioventricular block); 2.Subjects with left ventricular ejection fraction <40%; 3.Subjects with unstable coronary artery disease; 4.Subjects with hepatic or renal impairment (Child-Pugh class C or receiving renal replacement therapy); 5.Subjects with abnormal blood coagulation function; 6.Subjects with infection at the puncture site; 7.Subjects with a history of Parkinson's disease or Alzheimer's disease; 8.Subjects with a history of epilepsy; 9.Subjects are breast feeding and pregnant women; 10.Subjects with a history of chronic pain or preoperative use of sedatives or analgesics; 11.Subjects with a history of allergy to local anesthetic drugs or any of the experimental medications; 12.Subjects with diabetic neuropathy; 13.Subjects with neurological disorders (e.g., stroke, hypesthesia); 14.Subjects with uncontrolled psychiatric disorders (e.g., anxiety, depression, schizophrenia).

Design outcomes

Primary

MeasureTime frame
Mean NRS pain scores during rest at 24, 48, and 72 hours after surgery;

Secondary

MeasureTime frame
NRS pain scores at rest and on activity at 24, 48 and 72 hours after surgery;Quality of recovery at 24, 48, and 72 hours after surgery;The total amount of opioid analgesics within 0-72 h postoperatively;The time to first press on the PCIA;Incidence of chronic pain at 90 days after surgery;Time to postoperative independent activities;Postoperative hospital stays;

Countries

China

Contacts

Public ContactFuhai Ji

The First Affiliated Hospital of Soochow University

jifuhai@hotmail.com+86 512 67780055

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026